Exjade and counts
Exjade is an effective drug for iron overload but can in rare cases lead to that the counts decrease and there is a new warning in Europe:
"THE COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE FEBRUARY 2009 PLENARY MEETING MONTHLY REPORT
THE COMMITTEE FOR MEDICINAL PRODUCTS FOR HUMAN USE introduced a new warning in section 4.4 of the summary of product characteristics for Exjade (deferasirox) following postmarketing reports (both spontaneous and from clinical trials) of pancytopenia or aggravation of pancytopenia in patients treated with Exjade. Exjade is indicated for the treatment of chronic iron overload due to frequent blood transfusions".
|All times are GMT -4. The time now is 11:58 PM.|
Powered by vBulletin® Version 3.6.7
Copyright ©2000 - 2020, Jelsoft Enterprises Ltd.
Forum sites may contain non-authoritative and unverified information.
Medical decisions should be made in consultation with qualified medical professionals.
Site contents exclusive of member posts Copyright © 2006-2020 Marrowforums.org